Translational Psychiatry (Jan 2024)

Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis

  • Emma L. Twait,
  • Jen-Hao Wu,
  • Maria Kamarioti,
  • Maartje Basten,
  • Wiesje M. van der Flier,
  • Lotte Gerritsen,
  • Mirjam I. Geerlings

DOI
https://doi.org/10.1038/s41398-024-02739-9
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Several lines of evidence have indicated that depression might be a prodromal symptom of Alzheimer’s disease (AD). This systematic review and meta-analysis investigated the cross-sectional association between amyloid-beta, one of the key pathologies defining AD, and depression or depressive symptoms in older adults without dementia. A systematic search in PubMed yielded 689 peer-reviewed articles. After full-text screening, nine CSF studies, 11 PET studies, and five plasma studies were included. No association between amyloid-beta and depression or depressive symptoms were found using cerebrospinal fluid (CSF) (0.15; 95% CI: −0.08; 0.37), positron emission topography (PET) (Cohen’s d: 0.09; 95% CI: −0.05; 0.24), or plasma (−0.01; 95% CI: −0.23; 0.22). However, subgroup analyses revealed an association in plasma studies of individuals with cognitive impairment. A trend of an association was found in the studies using CSF and PET. This systematic review and meta-analysis suggested that depressive symptoms may be part of the prodromal stage of dementia.